The ACIP’s recommendation of influenza vaccination during
pregnancy is not supported by citations in its own policy paper or in
current medical literature. Considering the potential risks of
maternal and fetal mercury exposure, the administration of
thimerosal during pregnancy is both unjustified and unwise.
Pregnancy should continue to be a time when doctors are highly
protective of their patients with regard to any fetal exposure.
Without adequate safety testing, a risk-benefit analysis of influenza
vaccination during pregnancy is not possible, and therefore the
ACIP’s present recommendation should be withdrawn